INGNÂ – Inogen, Inc.
Float Short %
3.83
Margin Of Safety %
Put/Call OI Ratio
0.09
EPS Next Q Diff
-0.08
EPS Last/This Y
1.06
EPS This/Next Y
0.1
Price
7.76
Target Price
11
Analyst Recom
2.33
Performance Q
14.81
Relative Volume
0.91
Beta
1.76
Ticker: INGN
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-07-25 | INGN | 6.8 | 0.10 | 0.00 | 1118 |
| 2025-07-28 | INGN | 6.8 | 0.10 | 0.00 | 1153 |
| 2025-07-29 | INGN | 6.6 | 0.10 | 0.00 | 1163 |
| 2025-07-30 | INGN | 6.56 | 0.10 | 0.10 | 1162 |
| 2025-07-31 | INGN | 6.32 | 0.10 | 0.00 | 1167 |
| 2025-08-01 | INGN | 6.23 | 0.09 | 0.20 | 1187 |
| 2025-08-04 | INGN | 6.53 | 0.10 | 0.00 | 1239 |
| 2025-08-05 | INGN | 6.33 | 0.10 | 0.00 | 1240 |
| 2025-08-06 | INGN | 6.3 | 0.10 | 0.00 | 1240 |
| 2025-08-07 | INGN | 5.89 | 0.10 | 0.00 | 1243 |
| 2025-08-08 | INGN | 6.47 | 0.09 | 0.00 | 1307 |
| 2025-08-11 | INGN | 7.03 | 0.07 | 0.10 | 1448 |
| 2025-08-12 | INGN | 7.58 | 0.08 | 0.02 | 1527 |
| 2025-08-13 | INGN | 7.7 | 0.09 | 0.00 | 1400 |
| 2025-08-14 | INGN | 7.68 | 0.09 | 0.00 | 1378 |
| 2025-08-15 | INGN | 7.49 | 0.09 | 0.00 | 1378 |
| 2025-08-18 | INGN | 7.54 | 0.09 | 0.00 | 1213 |
| 2025-08-19 | INGN | 7.47 | 0.09 | 0.00 | 1213 |
| 2025-08-20 | INGN | 7.36 | 0.09 | 0.00 | 1214 |
| 2025-08-21 | INGN | 7.52 | 0.09 | 0.00 | 1214 |
| 2025-08-22 | INGN | 7.74 | 0.09 | 0.02 | 1216 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-07-25 | INGN | 6.80 | -28.6 | - | -0.53 |
| 2025-07-28 | INGN | 6.82 | -28.6 | - | -0.53 |
| 2025-07-29 | INGN | 6.60 | -28.6 | - | -0.53 |
| 2025-07-30 | INGN | 6.55 | -28.6 | - | -0.53 |
| 2025-07-31 | INGN | 6.31 | -28.6 | - | -0.53 |
| 2025-08-01 | INGN | 6.21 | -28.6 | - | -0.53 |
| 2025-08-04 | INGN | 6.54 | -28.6 | - | -0.53 |
| 2025-08-05 | INGN | 6.33 | -28.6 | - | -0.53 |
| 2025-08-06 | INGN | 6.31 | -28.6 | - | -0.53 |
| 2025-08-07 | INGN | 5.87 | -28.6 | - | -0.53 |
| 2025-08-08 | INGN | 6.48 | -28.6 | - | -0.53 |
| 2025-08-11 | INGN | 7.04 | -28.6 | - | -0.53 |
| 2025-08-12 | INGN | 7.59 | - | - | -0.53 |
| 2025-08-13 | INGN | 7.70 | - | - | -0.53 |
| 2025-08-14 | INGN | 7.68 | - | - | -0.53 |
| 2025-08-15 | INGN | 7.48 | - | - | -0.46 |
| 2025-08-18 | INGN | 7.56 | 18.2 | - | -0.46 |
| 2025-08-19 | INGN | 7.49 | 18.2 | - | -0.46 |
| 2025-08-20 | INGN | 7.36 | 18.2 | - | -0.46 |
| 2025-08-21 | INGN | 7.51 | 18.2 | - | -0.46 |
| 2025-08-22 | INGN | 7.76 | 18.2 | - | -0.46 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-07-25 | INGN | 0.40 | -3.56 | 4.25 |
| 2025-07-28 | INGN | 0.40 | -4.78 | 4.25 |
| 2025-07-29 | INGN | 0.40 | -4.78 | 4.25 |
| 2025-07-30 | INGN | 0.40 | -4.78 | 4.25 |
| 2025-07-31 | INGN | 0.40 | -4.78 | 4.25 |
| 2025-08-01 | INGN | 0.40 | -4.78 | 4.25 |
| 2025-08-04 | INGN | 0.40 | -4.89 | 4.25 |
| 2025-08-05 | INGN | 0.40 | -4.89 | 4.25 |
| 2025-08-06 | INGN | 0.40 | -4.89 | 4.25 |
| 2025-08-07 | INGN | 0.40 | -4.89 | 4.25 |
| 2025-08-08 | INGN | 0.40 | -4.89 | 4.25 |
| 2025-08-11 | INGN | 0.40 | -5.24 | 4.26 |
| 2025-08-12 | INGN | 0.40 | -5.24 | 3.85 |
| 2025-08-13 | INGN | 0.39 | -5.24 | 3.83 |
| 2025-08-14 | INGN | 0.39 | -5.24 | 3.83 |
| 2025-08-15 | INGN | 0.39 | -5.24 | 3.83 |
| 2025-08-18 | INGN | 0.39 | -8.40 | 3.83 |
| 2025-08-19 | INGN | 0.39 | -8.40 | 3.83 |
| 2025-08-20 | INGN | 0.39 | -8.40 | 3.83 |
| 2025-08-21 | INGN | 0.39 | -8.40 | 3.83 |
| 2025-08-22 | INGN | 0.39 | -8.40 | 3.83 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS​
-0.15
Avg. EPS Est. Current Quarter
-0.09
Avg. EPS Est. Next Quarter
-0.23
Insider Transactions
0.39
Institutional Transactions
-8.4
Beta
1.76
Average Sales Estimate Current Quarter
92
Average Sales Estimate Next Quarter
88
Fair Value
Quality Score
38
Growth Score
36
Sentiment Score
43
Actual DrawDown %
90.6
Max Drawdown 5-Year %
-94.9
Target Price
11
P/E
Forward P/E
PEG
P/S
0.61
P/B
1.05
P/Free Cash Flow
EPS
-1.06
Average EPS Est. Cur. Y​
-0.46
EPS Next Y. (Est.)
-0.36
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-7.58
Relative Volume
0.91
Return on Equity vs Sector %
-37.7
Return on Equity vs Industry %
-31.8
EPS 1 7Days Diff
0.1
EPS 1 30Days Diff
0.07
EBIT Estimation
Inogen, IncSector: Healthcare
Industry: Medical Devices
Employees: 766
Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One and Inogen Rove, an ambulatory solutions for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
stock quote shares INGNÂ – Inogen, Inc. Stock Price stock today
news today INGNÂ – Inogen, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch INGNÂ – Inogen, Inc. yahoo finance google finance
stock history INGNÂ – Inogen, Inc. invest stock market
stock prices INGN premarket after hours
ticker INGN fair value insiders trading